Pancragen

Where the compound comes from

The Khavinson programme began with peptide fractions extracted from animal organs — thymus, pineal, vessel, pancreas — and later replaced them with defined synthetic short sequences intended to reproduce the activity of each extract. Pancragen is the pancreatic member of that synthetic set, standing in the same relation to Suprefort as Vesugen does to vascular preparations and Testagen to testicular ones.

Proposed mechanism

Reported observations for KEDW

• Changes in expression of pancreatic transcription factors including Pdx1 and Ngn3 in cell culture
• Effects on insulin gene expression measures in islet-derived preparations
• Altered proliferation and apoptosis markers in cultures from aged donors
• Comparative work against other short peptides in the same series to test sequence specificity

Evidence quality

Keep the sealed vial at −20 °C, dry and shielded from light until the day of use, and allow it to reach room temperature before opening so condensation does not settle on the powder. Reconstitute by running bacteriostatic or sterile water slowly down the inside wall of the vial rather than directly onto the cake, then swirl gently until clear — do not shake or vortex, which shears peptide and causes foaming. Hold solutions at 2–8 °C protected from light and record the reconstitution date on the vial. For longer holds, prepare single-use aliquots and freeze them so repeated freeze–thaw cycles are avoided.